Literature DB >> 18824675

Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients.

L Fischer1, P Martus, M Weller, H A Klasen, B Rohden, A Röth, B Storek, M Hummel, T Nägele, E Thiel, A Korfel.   

Abstract

BACKGROUND: The impact of meningeal dissemination in primary CNS lymphoma (PCNSL) is debated, and the reported frequency varies. We prospectively evaluated the diagnostic value of PCR in comparison with CSF cytomorphology and MRI for diagnosing meningeal dissemination in PCNSL.
METHODS: We evaluated 282 patients from a multicenter therapy study for PCNSL for the presence of meningeal dissemination: 205 with CSF cytomorphology, 171 with PCR of the rearranged immunoglobulin heavy-chain genes in CSF, and 217 with cranial MRI.
RESULTS: Meningeal dissemination was found in 33 of 205 patients (16%) by cytomorphology, in 19 of 171 (11%) patients evaluated by PCR, and in 8 of 217 patients (4%) by MRI. Considering either of these methods, the relative frequency of meningeal dissemination was 17.4% (49 of 282 patients). PCR was monoclonal in 6 of 19 (32%) samples with positive cytomorphology, 1 of 13 samples (8%) with suspicious cytology, and in 10 of 105 (10%) cytologically negative samples. In 11 samples with positive and 12 with suspicious cytology, PCR showed only a polyclonal pattern. The probability of meningeal dissemination detection was higher in cases with CSF pleocytosis (>5/microL) with an OR of 2.48 (95% CI 1.15-5.34, p = 0.018). CSF protein had no predictive value for meningeal dissemination detection.
CONCLUSIONS: We found a low rate of meningeal dissemination in primary CNS lymphoma in this large prospective study. The rate of discordant PCR and cytomorphologic results was high. Thus, the methods should be regarded as complementary. CSF pleocytosis had predictive value for meningeal dissemination detection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824675     DOI: 10.1212/01.wnl.0000326958.52546.f5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  A 61-Year-Old Woman With Headaches and Aphasia.

Authors:  Adam Reynolds; Erica Byrd; Mahmud Mossa-Basha; Sandeep P Khot; Arielle Davis
Journal:  Neurohospitalist       Date:  2015-10

2.  Primary CNS lymphoma.

Authors:  Uwe Schlegel
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Advances in primary CNS lymphoma: randomized clinical trials of chemotherapy and whole-brain radiotherapy.

Authors:  Lauren E Abrey
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 4.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

Review 5.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

Review 6.  Advances in Primary Central Nervous System Lymphoma.

Authors:  Lauren B Patrick; Nimish A Mohile
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

7.  Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.

Authors:  Eugene L Scharf; Curtis A Hanson; Matthew T Howard; B Mark Keegan
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

8.  The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Authors:  Tilman Hottenrott; Elisabeth Schorb; Kristina Fritsch; Rick Dersch; Benjamin Berger; Daniela Huzly; Sebastian Rauer; Ludger Tebartz van Elst; Dominique Endres; Oliver Stich
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 9.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

10.  MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis.

Authors:  Dong Wei; Qun Wan; Li Li; Haifeng Jin; Yonghong Liu; Yangang Wang; Guangyun Zhang
Journal:  Mol Neurobiol       Date:  2014-08-01       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.